Certificate is Obtained
Biomedical complex Nanolek has received a GMP (Good Manufacturing Practice) Certificate. The corresponding order has been signed at the Ministry of Industry and Trade of the Russian Federation.
BMK Nanolek facility was constructed from the ground up. It was designed to manufacture solid pharmaceutical forms (antiretroviral therapy, oncology and cardiovascular products), and biotechnological formulations in syringes and vials.
Currently manufacturing facilities at NANOLEK include a line of antidiabetic and cardiological drugs. This year the facility will launch production of the first local inactivated polio vaccine, a pentavalent pediatric vaccine, antithrombosis injectionable drug and an agent for rheumatoid arthritis.